EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
On Tuesday, Kodak released its third-quarter report. The company reported a $8 million loss in consolidated revenues, from ...
European Union antitrust officials are asking rival pharmaceuticals firms for their input on Novo Holdings planned $16.5 ...
Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors? We'll need ...
Worldcategory COP29 Climate Summit: Guterres urged faster progress, as CO2 emissions to hit record high 3:24 PM UTC Boards, Policy & Regulationcategory EU regulators quiz Novo Nordisk, Catalent rivals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback